Michigan spin-off Alertwatch gains FDA clearance to sell its patient monitoring services.
Alertwatch, a medtech spin-out of the University of Michigan, has received clearance from the US Food and Drug Administration (FDA) to begin selling its patient monitoring services to hospitals. The start-up, which raised $1m last year for application to the FDA, displays easy-to-read data on patients during surgery. Its monitoring software draws on a range…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
